Trial Profile
Phase I/II Evaluation of the Safety, Pharmacokinetics, and Preliminary Effectiveness of Nikkomycin Z in the Treatment of Patients With Uncomplicated Coccidioides Pneumonia
Status:
Discontinued
Phase of Trial:
Phase I/II
Latest Information Update: 11 Jan 2016
Price :
$35
*
At a glance
- Drugs Nikkomycin Z (Primary)
- Indications Coccidioidomycosis
- Focus Adverse reactions
- 11 Jan 2016 New trial record